| 1 |
29310611 | Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy. | 2018 Jan 8 |
1 |
| 2 |
29696197 | Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial. | 2017 Dec |
1 |
| 3 |
26746689 | S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102). | 2016 Aug |
2 |
| 4 |
27229742 | A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study). | 2016 |
1 |
| 5 |
27468920 | Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study). | 2016 Sep |
1 |
| 6 |
27822036 | Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing. | 2016 |
2 |
| 7 |
24839048 | A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis. | 2015 Apr |
1 |
| 8 |
26148595 | Clinical study of tegafur-gimeracil-oteracil potassium capsule (s-1) and oxaliplatin combination chemotherapy in advanced colorectal cancer. | 2015 Apr-Jun |
1 |
| 9 |
23494222 | A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix. | 2014 Apr |
1 |
| 10 |
23629479 | Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer. | 2013 Aug |
1 |
| 11 |
24023346 | Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. | 2013 Sep |
1 |
| 12 |
18594218 | Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancer. | 2008 Aug |
1 |
| 13 |
16897986 | [S-1 as a single agent for colorectal cancer]. | 2006 Jun |
1 |
| 14 |
17106441 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. | 2006 Dec 18 |
1 |